Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
LABORATORIO REIG JOFRE ( (ES:RJF) ) has shared an announcement.
REIG JOFRE has been awarded a 13 million euro grant from the CDTi as part of the European IPCEI Med4Cure project, aimed at boosting pharmaceutical innovation. This grant supports REIG JOFRE’s EMINTECH project, which focuses on tackling global health challenges such as antimicrobial resistance and rare diseases through advanced therapies and cutting-edge technologies, enhancing the company’s strategic alignment with European health objectives.
More about LABORATORIO REIG JOFRE
REIG JOFRE is a pharmaceutical company listed on the Spanish stock exchange, specializing in the development, production, distribution, and marketing of essential health solutions, ranging from preventive care to critical medical situations.
Average Trading Volume: 34,762
Technical Sentiment Signal: Buy
Current Market Cap: €243.5M
Learn more about RJF stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue